← Open Payments lookup

JULIE GARBUTT: Open Payments

NPI 1720077092 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$500 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $500

Food & beverage: $500
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.4$119
ABBVIE INC.4$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$66
Otsuka America Pharmaceutical, Inc.2$55
Takeda Pharmaceuticals U.S.A., Inc.2$35
Axsome Therapeutics, Inc.1$29
Alkermes, Inc.1$27
Otsuka Pharmaceutical Development & Commercialization, Inc.1$22
Supernus Pharmaceuticals, Inc.1$22
Sage Therapeutics, LLC1$22

Products named: FANAPT, VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX, Auvelity, ARISTADA, REJOYN.

Industry payments across PA — which companies pay providers there.